نتائج البحث - Matteo Simonelli

  • يعرض 1 - 16 نتائج من 16
تنقيح النتائج
  1. 1
    Neutrophils in Gliomas

    Neutrophils in Gliomas حسب Matteo Massara, Pasquale Persico, Ornella Bonavita, Valeria Mollica Poeta, Massimo Locati, Matteo Simonelli, Raffaella Bonecchi

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Treatment with pembrolizumab in programmed death ligand 1–positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE‐028 trial

    Treatment with pembrolizumab in programmed death ligand 1–positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE‐028 trial حسب David A. Reardon, Tae Min Kim, Jean‐Sébastien Frénel, Matteo Simonelli, Juanita Lopez, Deepa S. Subramaniam, Lillian L. Siu, Hui Wang, Suba Krishnan, Karen Stein, Christophe Massard

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Insulin‐like growth factor‐1 receptor and phosphorylated AKT‐serine 473 expression in 132 resected thymomas and thymic carcinomas

    Insulin‐like growth factor‐1 receptor and phosphorylated AKT‐serine 473 expression in 132 resected thymomas and thymic carcinomas حسب Paolo Andrea Zucali, Iacopo Petrini, Elena Lorenzi, Maria J. Merino, Liang Cao, Luca Di Tommaso, Hye Seung Lee, Matteo Incarbone, Beatriz Walter, Matteo Simonelli, Massimo Roncalli, Armando Santoro, Giuseppe Giaccone

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

    A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis حسب Armando Santoro, Matteo Simonelli, Carlos Rodríguez de Lope, Paolo Andrea Zucali, Luis H. Camacho, Alessandro Granito, Neil Senzer, Lorenza Rimassa, Giovanni Abbadessa, Brian Schwartz, Maria Lamar, Ronald E. Savage, Jordi Bruix

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome

    Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome حسب Marco Rossi, Federico Ambrogi, Lorenzo Gay, Marcello Gallucci, Marco Conti Nibali, Antonella Leonetti, Guglielmo Puglisi, Tommaso Sciortino, Henrietta Howells, Marco Riva, Federico Pessina, Pierina Navarria, Ciro Franzese, Matteo Simonelli, Roberta Rudà, Lorenzo Bello

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas

    Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas حسب Marco Rossi, Lorenzo Gay, Federico Ambrogi, Marco Conti Nibali, Tommaso Sciortino, Guglielmo Puglisi, Antonella Leonetti, Cristina Mocellini, Manuela Caroli, Susanna Cordera, Matteo Simonelli, Federico Pessina, Piera Navarria, Andrea Pace, Riccardo Soffietti, Roberta Rudà, Marco Riva, Lorenzo Bello

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

    Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin حسب Paolo Andrea Zucali, Elisa Giovannetti, Annarita Destro, Manlio Mencoboni, Giovanni Luca Ceresoli, Letizia Gianoncelli, Elena Lorenzi, Fabio De Vincenzo, Matteo Simonelli, Matteo Perrino, Andrea Bruzzone, Erik Thunnissen, G Tunesi, Laura Giordano, Massimo Roncalli, Godefridus J. Peters, Armando Santoro

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

    Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors حسب Igor Puzanov, Jeffrey A. Sosman, Armando Santoro, Muhammad Wasif Saif, Laura W. Goff, Grace K. Dy, Paolo Andrea Zucali, Julie A. Means‐Powell, Wen Wee, Matteo Simonelli, Robert E. Martell, Feng Chai, Maria Lamar, Ronald E. Savage, Brian Schwartz, Alex A. Adjei

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal

    Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal حسب Patrick A. Ott, Sarina A. Piha‐Paul, Pamela N. Münster, Michael J. Pishvaian, Emilie M.J. van Brummelen, Roger B. Cohen, Carlos Gomez‐Roca, Samuel Ejadi, Mark N. Stein, Emily Chan, Matteo Simonelli, Anne Morosky, Sanatan Saraf, Kenneth Emancipator, Minori Koshiji, Jaafar Bennouna

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation

    Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation حسب Francesca Orzan, Francesca De Bacco, Elisabetta Lazzarini, Giovanni Crisafulli, Alessandra Gasparini, Angelo Dipasquale, Ludovic Barault, Marco Macagno, Pasquale Persico, Federico Pessina, Beatrice Bono, Laura Giordano, Pietro Zeppa, Antonio Melcarne, Paola Cassoni, Diego Garbossa, Armando Santoro, Paolo M. Comoglio, Stefano Indraccolo, Matteo Simonelli, Carla Boccaccio

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

    Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesotheliom... حسب Vanesa Gregorc, Paolo Andrea Zucali, Armando Santoro, Giovanni Luca Ceresoli, Giovanni Citterio, Tommaso Martino De Pas, Nicoletta Zilembo, Fabio De Vincenzo, Matteo Simonelli, Gilda Rossoni, Anna Spreafico, Maria Grazia Viganò, Floriana Fontana, Filippo de Braud, Emilio Bajetta, Federico Caligaris‐Cappio, Paolo Bruzzi, A. Lambiase, Claudio Bordignon

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study

    Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study حسب Giuseppe Lombardi, Valeria Barresi, Stefano Indraccolo, Michele Simbolo, Matteo Fassan, Susanna Mandruzzato, Matteo Simonelli, Mario Caccese, Marco Pizzi, Arianna Fassina, Marta Padovan, Elena Masetto, Marina Paola Gardiman, Maria Giuseppina Bonavina, Maria Caffo, Pasquale Persico, Franco Chioffi, Luca Denaro, Angelo Paolo Dei Tos, Aldo Scarpa, Vittorina Zagonel

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions

    NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions حسب Valentina Cazzetta, Elena Bruni, Sara Terzoli, Claudia Carenza, Sara Franzese, Rocco Piazza, Paolo Marzano, Matteo Donadon, Guido Torzilli, Matteo Cimino, Matteo Simonelli, Lorenzo Bello, Anna Villa, Likai Tan, Sarina Ravens, Immo Prinz, Domenico Supino, Federico Colombo, Enrico Lugli, Emanuela Marcenaro, Éric Vivier, Silvia Della Bella, Joanna Mikulak, Domenico Mavilio

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events

    Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events حسب Agnese Losurdo, Cristina Panico, C Catalano, Simone Serio, Laura Giordano, Lorenzo Monti, Federica Catapano, Stefano Figliozzi, C. D’Andréa, Angelo Dipasquale, Pasquale Persico, Antonio Di Muzio, M. Cremonesi, Alessandro Marchese, Maria Chiara Tronconi, Matteo Perrino, Giovanna Finocchiaro, Enrico Lugli, Marco Francone, Armando Santoro, Gianluigi Condorelli, Matteo Simonelli, Marinos Kallikourdis

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer

    First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer حسب Timothy A. Yap, María Vieito, Capucine Baldini, Juan Manuel Sepúlveda-Sánchez, Shunsuke Kondo, Matteo Simonelli, Rasha Cosman, André van der Westhuizen, Victoria Atkinson, Alain Carpentier, Mario Löhr, Rebecca Redman, Warren Mason, Andrés Cervantes, Émilie Le Rhun, Sebastian Ochsenreither, Louise Warren, Yumin Zhao, Sophie Callies, Shawn T. Estrem, Michael Man, Leena Gandhi, Emin Avşar, Davide Melisi

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma

    REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma حسب Mario Caccese, Isacco Desideri, Veronica Villani, Matteo Simonelli, Michela Buglione, Silvia Chiesa, Enrico Franceschi, Paola Gaviani, I. Stasi, Claudia Caserta, S. Brugnara, Ivan Lolli, E. Bennicelli, Paola Bini, A.S. Cuccu, Silvia Scoccianti, Marta Padovan, Stefania Gori, A. Bonetti, Pasqualina Giordano, Alessia Pellerino, Fabiana Gregucci, N. Riva, S. Cinieri, Valeria Internò, Matteo Santoni, Gianfranco Pernice, Cristina Dealis, L. Stievano, Fabiola Paiar, Giovanna Magni, Gian Luca De Salvo, Vittorina Zagonel, Giuseppe Lombardi

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: